Axa S.A. Taro Pharmaceutical Industries LTD Transaction History

Axa S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$62.34 - $73.38 $430,146 - $506,321	-6,900 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$70.26 - $76.64 $182,676 - $199,264	2,600 Added 60.47%	6,900 $497,000
Q1 2021 May 14, 2021	SELL	$70.48 - $79.95 $838,712 - $951,405	-11,900 Reduced 73.46%	4,300 $317,000
Q3 2020 Nov 13, 2020	SELL	$54.41 - $68.2 $984,820 - $1.23 Million	-18,100 Reduced 52.77%	16,200 $889,000
Q2 2020 Aug 14, 2020	BUY	$61.66 - $70.16 $894,070 - $1.02 Million	14,500 Added 73.23%	34,300 $2.28 Million
Q1 2020 May 15, 2020	BUY	$59.35 - $88.73 $1.18 Million - $1.76 Million	19,800 New	19,800 $1.21 Million
Q4 2019 Feb 18, 2020	SELL	$74.18 - $97.92 $655,973 - $865,906	-8,843 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$75.36 - $86.57 $666,408 - $765,538	8,843 New	8,843 $667,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.